Zydus Lifesciences Limited (ZYDUSLIFE) Share Analysis
NSE · Healthcare · Pharmaceuticals
Zydus Lifesciences Limited (NSE: ZYDUSLIFE) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 100, NIFTY 200, NIFTY 500. As of 21 Sep 2026, the share price was ₹1,160.00, market capitalisation ₹1,15,710 Cr, P/E 23.8, ROE 21.2%.
Get the AI verdict on ZYDUSLIFE: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
ZYDUSLIFE price and valuation
- Share price
- ₹1,160.00
- Market cap
- ₹1,15,710 Cr
- P/E ratio
- 23.8
- P/B ratio
- 4.31
- EPS
- ₹44.94
- Book value per share
- ₹269.00
- Dividend yield
- 0.09%
ZYDUSLIFE profitability and growth
- ROE
- 21.2%
- ROCE
- 21.1%
- Debt to equity
- 0.42
- Revenue growth (3 yr)
- 16%
- Revenue growth (5 yr)
- 12%
- Profit growth (3 yr)
- 32%
- Profit growth (5 yr)
- 19%
ZYDUSLIFE 52-week range
- 52-week high
- ₹1,205.00
- 52-week low
- ₹835.50
- Face value
- ₹1.00
ZYDUSLIFE shareholding pattern
- Promoters
- 75.02%
- FIIs
- 6.89%
- DIIs
- 11.27%
- Public
- 6.83%
Index membership: NIFTY 100, NIFTY 200, NIFTY 500, NIFTY Healthcare Index, NIFTY Next 50, NIFTY Pharma.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.